France· FR:67351693
NUWIQ 500 UI, poudre et solvant pour solution injectable
A simoctocog alfa product containing simoctocog alfa, registered in France by OCTAPHARMA (SUEDE). The same ATC class is registered in 2 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Simoctocog alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD44 (simoctocog alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Simoctocog alfa · ATC B02BD44
2 / 19 countries
- Franceprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SIMOCTOCOG ALFA
- Manufacturer
- OCTAPHARMA (SUEDE)
- Country
- France (FR)
- ATC code
- B02BD44
- ATC class
- Simoctocog alfa
- Defined daily dose
- 1 TSD, E
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550040351 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 2,5 ml avec aiguille(s) avec tampon(s) alcoolisé(s) avec dispositif(s) de transfert
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Simoctocog alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsNuwiq 500 IE poeder en oplosmiddel voor oplossing voor injectieOctapharma AB
- BelgiumNuwiq 1000 IUOctapharma
- FinlandNuwiqOctapharma AB
- IrelandNuwiq 1000 IU powder and solvent for solution for injectionOctapharma AB
- PolandNuwiqOctapharma AB
- SwedenNuwiq 1000 IE Pulver och vätska till injektionsvätska, lösningOctapharma AB
- SpainNUWIQ 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEOctapharma Ab
- CzechiaNUWIQOctapharma AB, Stockholm
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nuwiq
- Liechtenstein · Nuwiq
- Norway · Nuwiq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/36a2fb2b-727f-4f6b-8e32-dbd692bc3ec3 GET /v1/drugs/36a2fb2b-727f-4f6b-8e32-dbd692bc3ec3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67351693",
"date_amm": "2014-07-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/936",
"substance": "SIMOCTOCOG ALFA",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about simoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.